Bioventus Inc.
BVS
Revenue
151.22M
▲21.76M▲16.81%
3 Months ChangeAssets
792.17M
▼-2.07M▼-0.2600%
3 Months ChangeLiabilities
603.11M
▲26.31M▲4.56%
3 Months ChangeFree Cash Flow
-6.30M
▼-5.23M▼-488.41%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-04
Form 8-K
ID: 0001628280-24-042266
2024-08-06
Form 10-Q
ID: 0001628280-24-034979
2024-08-06
Form 8-K
ID: 0001628280-24-034976
2024-07-19
Form 8-K
ID: 0001193125-24-181655
2024-06-21
Form 8-K
ID: 0001193125-24-165735
2024-06-17
Form 8-K
ID: 0001193125-24-162669
2024-05-07
Form 10-Q
ID: 0001628280-24-020846
2024-05-07
Form 8-K
ID: 0001628280-24-020843
2024-03-12
Form 8-K
ID: 0001628280-24-010371
2024-01-19
Form 8-K
ID: 0001193125-24-010779